Home
Explore Technologies
Stanford OTL
The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact
|
Explore Technologies
Atom Economic Asymmetric Aldol and Related Reactions
Stanford Reference:
00-194
Abstract
Carbonyl addition reactions are very prominent in the synthesis of complex molecules. The classic aldol is illustrative, but the reaction suffers from poor chemo- and regioselectivity. Researchers in the laboratory of Dr. Barry Trost at Stanford University have developed a catalytic system that provides an exceptionally efficient way to effect aldol and the related nitroaldol to form chiral, enantiopure adducts. Furthermore, other nucleophiles like cyanide and terminal alkynes are suitable. In addition to aldehydes, imines also serve as acceptors to provide chiral enantiopure amines.
The catalyst involves a novel dinuclear main group metal (presently mainly zinc) complex that self assembles with a chiral ligand to produce compounds that are important building blocks for further organic synthesis. Because of the extraordinary chemoselectivity, diastereoselectivity, and enantioselectivity of the catalysis, this technology should be particularly useful for the synthesis of pharmaceuticals, natural products, and agrichemicals.
Ongoing Research:
The potential of this catalyst system has been scarcely examined. On-going programs are examining the breadth of possible donors and acceptors suitable for catalysis with these complexes. For example, promising leads for asymmetric conjugate additions and formation of cyclic amines are being developed.
Applications
Fine chemicals
- synthesis of chiral intermediates
Pharmaceutical synthesis
- natural products and small molecules
Agrichemical synthesis
Advantages
Versatile
-
Reaction works with a variety of ketones, nitroalkyls, carbonyls, and imines
Catalyst can be used for aldol, nitroaldol, and other reactions
Inexpensive
-
High atom economy of reaction
Low cost of chiral ligand
Catalyst utilizes low cost metal
Easy
- chiral ligand readily available
Non-toxic
metal in catalyst
Publications
B.M. Trost and H. Ito
"A Direct Catalytic Enantioselective Aldol Reaction via a Novel Catalyst Design,"
J Am Chem Soc
2000, 22, 12003-12004.
Trost BM, Ito H, Silcoff Er.
"Asymmetric aldol reaction via a dinuclear zinc catalyst: alpha-hydroxyketones as donors"
J Am Chem Soc.
2001 Apr 11:123(14):3367-8.
Trost BM, Silcoff ER, Ito H.
"Direct asymmetric aldol reactions of acetone using bimetallic zinc catalysts"
Org Lett.
2001 Aug 9;3(16):2497-500.
Trost BM, Yeh VS.
"A dinuclear Zn catalyst for the asymmetric nitroaldol (Henry) reaction."
Angew Chem Int Ed Engl.
2002 Mar 1;41(5):861-3.
Trost BM, Yeh VS, Ito H, Bremeyer N.
"Effect of ligand structure on the zinc-catalyzed Henry reaction: Asymmetric syntheses of (-)-denopamine and (-)-arbutamine."
Org Lett.
2002 Aug 8:4(16):2621-3.
Trost BM, Yeh VS,
"Stereocontrolled synthesis of (+)-boronolide"
Org Lett.
2002 Oct 3:4(20):3213-6.
Trost BM, Terrell LR.
"A direct catalytic asymmetric mannich-type reaction to syn-amino alcohols."
J Am Chem Soc.
2003 Jan 15;125(2):338-9.
Trost BM, Fettes A, Shireman BT.
"Direct catalytic asymmetric aldol additions of methyl ynones. Spontaneous reversal in the sense of enantioinduction."
J Am Chem Soc.
2004 Mar 10;126(9):2660-1.
Trost BM, Frederiksen MU, Papillon JP, Harrington PE, Shin S, Shireman BT.
"Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecin."
J Am Chem Soc.
2005 Mar 23:127(11):3666-7.
Lab Web Site
Web Page of B.M. Trost Group
Innovators & Portfolio
Hisanaka Ito
Barry Trost
Patent Status
Published Application: WO200241984
Published Application: 20040019239
Issued : 6,610,889 (USA)
Issued : 6,919,456 (USA)
Date Released
3/2/2015 12:00
Licensing Contact
Irit Gal, Senior Licensing Manager
650-723-1586 (Business)
Request Info
03-249
Catalytic Depolymerization of Polymers
05-009
Production of Hydrogenase Activity in a Cell-Free Protein Synthesis System
06-457
Cell Line for Optically-based Screening of Ion Channel Modulators
more technologies »
Related Keywords
PS: chemicals: catalyst
chiral
PS: chemicals: synthesis & production
LS: general therapeutic: natural product
LS: small molecule therapeutic
intermediates
00-194
chemical